4//SEC Filing
Wells David R. 4
Accession 0001209191-19-047405
CIK 0001681682other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:18 PM ET
Size
7.4 KB
Accession
0001209191-19-047405
Insider Transaction Report
Form 4
Wells David R.
Chief Financial Officer
Transactions
- Purchase
Common Stock
2019-08-23$1.55/sh+5,000$7,750→ 10,000 total - Purchase
Common Stock
2019-08-22$1.56/sh+5,000$7,800→ 5,000 total
Holdings
- 24,786(indirect: By StoryCorp Consulting)
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.55 to $1.59, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001480371
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:18 PM ET
- Size
- 7.4 KB